Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FRYCK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,332
Award facts
- Contract value 100% obligated
- $39,332.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,332.07 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injections on May 30, 2025, with completion scheduled for June 2, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for pharmaceutical supply to federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for global pharmaceutical support to military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates significant capability in delivering a comprehensive range of pharmaceutical products across multiple therapeutic domains. This Dupixent order continues AmerisourceBergen's role as a key pharmaceutical supplier under the DLA's comprehensive medical supply chain, which is planning future Pharmaceutical Prime Vendor Global Program Generation V contracts intended for multiple regional awards across multiple contractors.
Quick answers
Who was awarded contract SPE2DB25FRYCK?
SPE2DB25FRYCK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FRYCK worth?
The government has obligated $39,332 on SPE2DB25FRYCK.
Is contract SPE2DB25FRYCK an order under another contract?
Yes. SPE2DB25FRYCK is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FRYCK competed?
The extent of competition for SPE2DB25FRYCK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award